Literature DB >> 16079045

Psychiatric manifestations of autoimmune disorders.

David B Weiss1, Jarl Dyrud, Robert M House, Thomas P Beresford.   

Abstract

Psychiatric symptoms are common to many autoimmune disorders. Patients often will have mood disorders, anxiety, cognitive deficits, delirium, and psychosis. These symptoms may reflect the direct or indirect effect of the autoimmune disorder on the central nervous system, may be related to medications used to treat the disorder, or may be a direct psychologic impact from suffering with the autoimmune disorder. Accurately recognizing the psychiatric component and generating a differential diagnosis is a complex task for the treating physician. Treatment of the psychiatric component to the disorder often will include addressing steroid induced side effects, psychotropic medications, psychotherapy, patient and family education, and a strong physician-patient relationship.

Entities:  

Year:  2005        PMID: 16079045     DOI: 10.1007/s11940-005-0033-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  34 in total

1.  Depressive symptoms associated with scleroderma.

Authors:  R P Roca; F M Wigley; B White
Journal:  Arthritis Rheum       Date:  1996-06

2.  Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years.

Authors:  M P Amato; G Ponziani; G Siracusa; S Sorbi
Journal:  Arch Neurol       Date:  2001-10

Review 3.  Hashimoto encephalopathy: syndrome or myth?

Authors:  Ji Y Chong; Lewis P Rowland; Robert D Utiger
Journal:  Arch Neurol       Date:  2003-02

Review 4.  Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.

Authors:  Peter Rieckmann; Mathias Mäurer
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

5.  Psychiatric symptoms associated with scleroderma.

Authors:  N V Angelopoulos; A A Drosos; H M Moutsopoulos
Journal:  Psychother Psychosom       Date:  2001 May-Jun       Impact factor: 17.659

6.  Depression in sarcoidosis.

Authors:  B Chang; J Steimel; D R Moller; R P Baughman; M A Judson; H Yeager; A S Teirstein; M D Rossman; C S Rand
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

7.  The impact of pain and symptoms of depression in scleroderma.

Authors:  Lisa M Benrud-Larson; Jennifer A Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley
Journal:  Pain       Date:  2002-02       Impact factor: 6.961

8.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  C Diaz-Olavarrieta; J L Cummings; J Velazquez; C Garcia de la Cadena
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

9.  An examination of suicidal intent in patients with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

10.  A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration.

Authors:  Olga Ciccarelli; David J Werring; Gareth J Barker; Colette M Griffin; Claudia A M Wheeler-Kingshott; David H Miller; Alan J Thompson
Journal:  J Neurol       Date:  2003-03       Impact factor: 4.849

View more
  3 in total

1.  Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder.

Authors:  Aoife O'Donovan; Beth E Cohen; Karen H Seal; Dan Bertenthal; Mary Margaretten; Kristen Nishimi; Thomas C Neylan
Journal:  Biol Psychiatry       Date:  2014-06-28       Impact factor: 13.382

2.  Polyglandular autoimmune syndrome disguised as mental illness.

Authors:  Randy Wei; Allen Chang; Aaron Rockoff
Journal:  BMJ Case Rep       Date:  2013-04-29

3.  Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?

Authors:  Charlotte Björkenstam; Petter Tinghög; Philip Brenner; Ellenor Mittendorfer-Rutz; Jan Hillert; Jussi Jokinen; Kristina Alexanderson
Journal:  BMC Psychiatry       Date:  2015-11-16       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.